Skip to main content

Day: May 23, 2023

United Lithium Drill Results Confirm Two New Discoveries at the Bergby Lithium Project Sweden

Figure 1 Geology Map showing the location of lithium bearing pegmatites A, B and C as well as drill holes and barren pegmatites.VANCOUVER, British Columbia, May 23, 2023 (GLOBE NEWSWIRE) — United Lithium Corp. (“United” or the “Company”) (CSE: ULTH; OTC: ULTHF; FWB: 0ULA) is pleased to announce that it continues to make lithium pegmatite discoveries at the Bergby Lithium Project (“Bergby” or the “Project”). Bergby is a 100% owned, district-scale, hard rock lithium project covering 10,828 hectares (“ha”) near the coast of the Gulf of Bothnia in Central Sweden. The Project area is characterized by LCT (lithium-cesium-tantalum enriched-type) granitic pegmatites. The final set of core assay results from the 2022 drilling campaign have now been received and evaluated. The 2023 drilling program, comprising 4,000 metres (“m”) of core...

Continue reading

Aduro Clean Technologies Announces $1.49 Million in Proceeds from Exercise of Warrants

Aduro Clean Technologies Announces $1.49 Million in Proceeds from Exercise of Warrants The Company has received total proceeds of $1,490,035 from the exercise of 1,862,544 warrants between November 9, 2022, and May 12, 2023.SARNIA, Ontario, May 23, 2023 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQB: ACTHF) (FSE: 9D50), a Canadian technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, is pleased to announce the successful exercise of warrants by its shareholders. The Company has received total proceeds of $1,490,035 from the exercise of 1,862,544 warrants between November 9, 2022, and May 12, 2023. Accordingly, the Company issued 1,862,544 common shares upon...

Continue reading

Alaris Announces TSX Acceptance of Normal Course Issuer Bid

NOT FOR DISTRIBUTION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY VIOLATE UNITED STATES SECURITIES LAW. CALGARY, Alberta, May 23, 2023 (GLOBE NEWSWIRE) — Alaris Equity Partners Income Trust (“Alaris” or the “Trust“) (TSX: AD.UN) is announcing that it has received approval from the Toronto Stock Exchange (“TSX“) to proceed with a normal course issuer bid (“NCIB“). Under the NCIB, the Trust may purchase for cancellation up to 1,000,000 trust units of the Trust (“Units“). As at May 23, 2023, Alaris had 45,479,179 Units outstanding. As a result, the NCIB represents approximately 2% of Alaris’ issued and outstanding Units as at May 23, 2023. The actual number of Units that may be purchased for cancellation under the NCIB and the timing of any such purchases...

Continue reading

New Report Reveals Untapped Youth Market for Banks and Credit Unions

Latest Cornerstone Advisors report explores how financial institutions can serve the next generation of banking customers by offering a family digital wallet experience BLUE BELL, Pa., May 23, 2023 (GLOBE NEWSWIRE) — Today, Rego Payment Architectures, Inc. (“REGO”) (OTCQB: RPMT) announced the release of “The Rise of Family Digital Wallets: Unlocking Opportunities for Banks and Credit Unions,” a new research report from Cornerstone Advisors. “Family digital wallets” provide children with a digital-first approach to banking with features and functionality that allow their parents to monitor and control their behavior. The report explores how family digital wallets can help financial institutions address the needs of underserved banking generations. According to the report, there are roughly 53.4 million children between the...

Continue reading

AutoZone 3rd Quarter Same Store Sales Increase 1.9%; EPS Increases to $34.12

MEMPHIS, Tenn., May 23, 2023 (GLOBE NEWSWIRE) — AutoZone, Inc. (NYSE: AZO) today reported net sales of $4.1 billion for its third quarter (12 weeks) ended May 6, 2023, an increase of 5.8% from the third quarter of fiscal 2022 (12 weeks). Domestic same store sales, or sales for stores open at least one year, increased 1.9% for the quarter. “I would like to congratulate and thank our entire organization for delivering solid earnings in our third fiscal quarter. The hard work of our AutoZoners and their dedication to providing superior customer service, again drove our quarterly performance. While weaker than expected sales for the month of March meaningfully affected our results this quarter, we are excited about our initiatives and believe we are well positioned for future growth,” said Bill Rhodes, Chairman, President and Chief...

Continue reading

U.S. Home Infusion Therapy Market Size to Surpass USD 33.20 billion by 2030, exhibiting a CAGR of 8.4%

As per the report by Fortune Business Insights, the global U.S. Home Infusion Therapy Market size is projected to reach USD 33.20 billion in 2030, at a CAGR of 8.4% during the forecast period, 2023-2030 Pune, India, May 23, 2023 (GLOBE NEWSWIRE) — The U.S. home infusion therapy market size was valued at USD 17.26 billion in 2022. The market is projected to expand from USD 18.82 billion in 2023 to USD 33.20 billion by 2030, exhibiting a CAGR of 8.4% during the forecast period. Home infusion therapy refers to the administration of medicines through a subcutaneous or intravenous route to an individual in the comfort of their home. It has been proven to be an effective and safe alternative to patient care at hospitals. The high cost of hospital stays, growing remote patient monitoring reimbursement, and a growing number of infusion...

Continue reading

Tardive Dyskinesia Therapeutics Market Size to Surpass USD 5.09 billion by 2030, exhibiting a CAGR of 9.1%

As per the report by Fortune Business Insights, the global tardive dyskinesia therapeutics market size is projected to reach USD 5.09 billion by 2030, at a CAGR of 9.1% during the forecast period Pune, India, May 23, 2023 (GLOBE NEWSWIRE) — According to Fortune Business Insights, the tardive dyskinesia therapeutics market size was valued at USD 2.33 billion in 2022 and is projected to grow from 2.77 billion in 2023 to USD USD 5.09 billion by 2030, exhibiting a CAGR of 9.1% during the forecast period. Tardive Dyskinesia (TD) is a side effect which is caused by the long-term usage of antipsychotic therapeutics. It is common in patients suffering from schizophrenia, schizoaffective disorder, or bipolar disorder. The government authorities, associations, and market players have been introducing initiatives to increase awareness regarding...

Continue reading

Specialty Generics Market Size to Surpass USD 200.80 billion by 2030, exhibiting a CAGR of 14.7%

As per the report by Fortune Business Insights, the global Specialty Generics Market size is projected to reach USD 200.80 billion in 2030, at a CAGR of 14.7% during the forecast period, 2023-2030 Pune, India, May 23, 2023 (GLOBE NEWSWIRE) — Fortune Business Insights said the global Specialty Generics Market size was valued at USD 67.89 billion in 2022. The market is projected to grow from USD 76.65 billion in 2023 to USD 200.80 billion by 2030, exhibiting a CAGR of 14.7% during the forecast period. Speciality generics refer to generic versions of speciality drugs after they get off-patent. These drugs are used to treat complex, chronic conditions such as cancer, multiple sclerosis, and rheumatoid arthritis. The growing generic population and patent expiration of several branded speciality drugs are expected to drive market growth....

Continue reading

Insulin Pump Market Size to Surpass USD 15.51 Billion by 2030, exhibiting a CAGR of 16.2%

As per the report by Fortune Business Insights, the global Insulin Pump Market size is projected to reach USD 15.51 billion in 2030, at a CAGR of 16.2% during the forecast period, 2023-2030 Pune, India, May 23, 2023 (GLOBE NEWSWIRE) — According to Fortune Business Insights, global Insulin Pump Market size was valued at USD 4.60 billion in 2022 and is projected to grow from USD 5.23 billion in 2023 to USD 15.51 billion by 2030, exhibiting a CAGR of 16.2% during the forecast period. Insulin pumps are compact, computerized devices that supply pre-determined doses of insulin to a diabetic person. Since the prevalence of type 1 diabetes is increasing at a worrying rate across the world, the demand for these devices has risen tremendously, thereby boosting the global insulin pump market growth. Fortune Business Insights presents this...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.